| __timestamp | Taro Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 179279000 | 9216000000 |
| Thursday, January 1, 2015 | 186359000 | 8296000000 |
| Friday, January 1, 2016 | 171785000 | 10044000000 |
| Sunday, January 1, 2017 | 208136000 | 11560000000 |
| Monday, January 1, 2018 | 198405000 | 10558000000 |
| Tuesday, January 1, 2019 | 224169000 | 9351000000 |
| Wednesday, January 1, 2020 | 245044000 | 8933000000 |
| Friday, January 1, 2021 | 252314000 | 8284000000 |
| Saturday, January 1, 2022 | 268225000 | 7952000000 |
| Sunday, January 1, 2023 | 304629000 | 8200000000 |
| Monday, January 1, 2024 | 324203000 | 8480000000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, understanding cost dynamics is crucial. Teva Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. have shown distinct trends in their cost of revenue from 2014 to 2023. Teva, a global leader, has seen its cost of revenue fluctuate, peaking in 2017 with a 15% increase from 2016, before gradually declining by 31% by 2022. Meanwhile, Taro, a more niche player, has experienced a steady rise, with costs increasing by 80% over the same period. This divergence highlights Teva's strategic adjustments in a volatile market, while Taro's consistent growth reflects its focused operational efficiency. Notably, data for Teva in 2024 is missing, suggesting potential reporting delays or strategic shifts. These insights underscore the importance of cost management in sustaining competitive advantage in the pharmaceutical industry.
AbbVie Inc. vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Novartis AG and Taro Pharmaceutical Industries Ltd.
Cost of Revenue Trends: Zoetis Inc. vs Teva Pharmaceutical Industries Limited
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Corcept Therapeutics Incorporated
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Cytokinetics, Incorporated
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Alkermes plc's Expenses
Cost of Revenue: Key Insights for Viatris Inc. and Taro Pharmaceutical Industries Ltd.
Analyzing Cost of Revenue: Pharming Group N.V. and Taro Pharmaceutical Industries Ltd.
Comparing Cost of Revenue Efficiency: Grifols, S.A. vs Taro Pharmaceutical Industries Ltd.
Cost of Revenue Comparison: MorphoSys AG vs Taro Pharmaceutical Industries Ltd.
Geron Corporation vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Taro Pharmaceutical Industries Ltd. vs Xencor, Inc.